Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

H5N1 virus mutating in humans, study finds
The human strain of H5N1 caused a more severe disease than the bovine strain.
Research found nine additional mutations in the human strain.

A study into the spread of H5N1 in the United States of America has revealed that the virus has developed new mutations in human hosts.

Researchers from Texas Biomedical Research Institute (Texas Biomed) identified nine additional mutations in the human strain of H5N1 compared to the strain present in bovines.

H5N1, commonly known as bird flu, is naturally found in wild birds and is lethal in chickens. It has since spread through a variety of mammals, first being identified in dairy cows in spring 2024.

The first reported death caused by H5N1 was reported in January 2025, as a result of exposure to infected chickens.

Researchers are increasingly concerned about the evolution of the virus, particularly of its potential to transmit from human to human. Texas Biomed has been studying H5N1 since the outbreak began last year, using specialised tools and animal models.

When comparing the human strain of H5N1 to the strain in bovines, researchers identified nine additional mutations which were believed to have occurred after human infection.

The study found that the human strain of H5N1 caused a more severe disease than the bovine strain. The human strain also replicated more efficiently and was found in much higher quantities in brain tissue.

However, the researchers did also identify that the mutations were not affecting the efficacy of approved antibiotics.

The researchers say that this is an important finding, as antibiotics will be vital if a pandemic does occur. Humans have no pre-existing immunity against H5N1, and seasonal flu vaccines offer limited protection.

Future research will see the team explore the human strain individually, investigating why infections from cows appear to be less harmful than from chickens. They will also examine why H5N1 causes mild disease in cows, but is lethal in cats.

Ahmed Mostafa Elsayed, staff scientist at Texas Biomed, said: "A key priority will be to eradicate bird flu from dairy cows to minimize risk of mutations and transmission to people and other species,

"Steps that can be taken now include thorough decontamination of milking equipment and more stringent quarantine requirements, which will help eliminate the virus more quickly in cows."

The full study can be found in the journal Emerging Microbes and Infections.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.